Ekaterina Vert-Wong | Vice President, Portfolio & Alliance Management
Sabin Vaccine Institute

Ekaterina Vert-Wong is the vice president of Research & Development Operations at the Sabin Vaccine Institute. In this role, she leads operational, organizational and alliance management functions. Since joining Sabin in 2021, she oversees R&D programs planning and execution and leads the development teams in the implementation of efficient operations and cost-effective systems to meet current and future needs of the organization. Ekaterina fosters Sabin’s internal and external collaborations to move vaccine development milestones forward, secure funding, and implement long-term pipeline strategies, internally and externally via effective alliance management. Ekaterina brings excellent knowledge of global vaccines R&D practices, proven record of success in leading medical innovation, including execution of all clinical phases and design of global regulatory strategies. Prior to joining Sabin, Ekaterina lead departments within innovative and dynamic research organizations, focusing on the development and testing of vaccines and biologics. She has more than 20 years of experience in product development, including development and licensure of BioThrax® for post-exposure prophylaxis and pre-exposure use in special populations at Emergent BioSolutions and development of anti-pertussis antibodies for passive vaccination applications under the alliance with the Gates Foundation she created while at Synthetic Biologics. Ekaterina received her graduate degree in Management from Dartmouth College and a graduate degree in Biochemistry from the Weizmann Institute of Science in Israel. Ekaterina is a dedicated medical innovator committed to bringing vaccines with high societal impacts to patients in need via ethical and equitable research pathways.